Allspring Global Investments Holdings, LLC Editas Medicine, Inc. Transaction History
Allspring Global Investments Holdings, LLC
- $54.8 Billion
- Q2 2025
A detailed history of Allspring Global Investments Holdings, LLC transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 12,046 shares of EDIT stock, worth $27,585. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,046
Previous 35,781
66.33%
Holding current value
$27,585
Previous $41,000
36.59%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding EDIT
# of Institutions
221Shares Held
48.1MCall Options Held
436KPut Options Held
324K-
Black Rock Inc. New York, NY7.78MShares$17.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.16MShares$16.4 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.66MShares$6.09 Million0.0% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL2.6MShares$5.95 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.96MShares$4.5 Million0.0% of portfolio
About Editas Medicine, Inc.
- Ticker EDIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,737,200
- Market Cap $157M
- Description
- Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...